Stat News • 9/28/2026

AbbVie has received FDA approval for its once-daily pill for Parkinson's disease. This approval is based on a late-stage study that demonstrated the drug's effectiveness in improving symptoms.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.









